On the other hand, the correlation between serum markers (e.g. CASP3, ESR1) and bone mineral density in the smoking population can be analyzed in conjunction with clinical cohort studies to assess the potential clinical effects of nicotine on osteoporosis. Here, CASP3 is linked to osteoporosis.